ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 230 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $104,504 | -32.8% | 19,175 | -17.3% | 0.00% | – |
| Q2 2023 | $155,551 | -29.7% | 23,182 | -7.5% | 0.00% | – |
| Q1 2023 | $221,209 | +29.3% | 25,052 | +11.8% | 0.00% | – |
| Q4 2022 | $171,144 | -2.8% | 22,401 | -9.4% | 0.00% | – |
| Q3 2022 | $176,000 | -17.4% | 24,721 | -6.0% | 0.00% | – |
| Q2 2022 | $213,000 | -17.1% | 26,299 | +42.0% | 0.00% | – |
| Q1 2022 | $257,000 | -80.2% | 18,521 | -59.9% | 0.00% | -100.0% |
| Q4 2021 | $1,297,000 | -15.6% | 46,206 | +2.2% | 0.00% | 0.0% |
| Q3 2021 | $1,537,000 | -16.5% | 45,221 | +0.4% | 0.00% | 0.0% |
| Q2 2021 | $1,841,000 | +5.5% | 45,057 | +3.9% | 0.00% | 0.0% |
| Q1 2021 | $1,745,000 | -2.8% | 43,350 | +42.7% | 0.00% | 0.0% |
| Q4 2020 | $1,796,000 | +82.5% | 30,378 | +50.1% | 0.00% | 0.0% |
| Q3 2020 | $984,000 | +137.1% | 20,233 | +135.9% | 0.00% | – |
| Q2 2020 | $415,000 | – | 8,577 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |